The cell and gene therapy CRO market presents growth opportunities driven by FDA-approved therapies, over 90 global approvals, and 3,500 trials across 16 therapeutic areas, primarily in North America.

The rollout of a type of genetic technology called a gene drive for tackling malaria could be edging closer after a lab study ...

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

The EU has agreed allow certain foods altered using genetic engineering techniques to be sold without special labeling under ...

Norovirus is the leading cause of gastroenteritis and is responsible for hundreds of thousands of deaths every year. However, ...

Northwestern Medicine investigators have identified issues with most genomic sequence data for the Neisseria gonorrhoeae ...

Europe’s firewall against genetic modification gets a major crack under a new deal. Crops tailor-made using new gene-splicing techniques should face fewer regulations than genetically modified ...

Karthik and her team aimed to use CRISPR as a way to identify and isolate a protein generated by the bacteria that cause Lyme ...

Tenaya Therapeutics remains pre-revenues, and it’s a thinly traded microcap. Its tight cash runway is also a concern. Read ...

Amid global climate change, Chinese scientists have recently made significant progress in understanding the heat tolerance ...

European lawmakers and EU member states announced late Wednesday they had reached an agreement on developing plants obtained ...

A Japanese government expert panel agreed Thursday to legally ban and penalize research or medical practices that genetically ...